Cargando…
The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
Liquid biopsy is a broad term that refers to the testing of body fluids for biomarkers that correlate with a pathological condition. While a variety of body-fluid components (e.g., circulating tumor cells, extracellular vesicles, RNA, proteins, and metabolites) are studied as potential liquid biopsy...
Autores principales: | Gezer, Ugur, Bronkhorst, Abel J., Holdenrieder, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221655/ https://www.ncbi.nlm.nih.gov/pubmed/35741173 http://dx.doi.org/10.3390/diagnostics12061363 |
Ejemplares similares
-
The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients
por: Gezer, Ugur, et al.
Publicado: (2022) -
The emerging role of cell-free DNA as a molecular marker for cancer management
por: Bronkhorst, Abel Jacobus, et al.
Publicado: (2019) -
Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line
por: Ungerer, Vida, et al.
Publicado: (2022) -
Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures
por: Oberhofer, Angela, et al.
Publicado: (2022) -
Cell-Free Nucleic Acids: Physico-Chemical Properties, Analytical Considerations, and Clinical Applications
por: Bronkhorst, Abel J., et al.
Publicado: (2023)